Combination anti-HIV antibody infusions suppress virus for prolonged period.
7 Jun, 2022 | 11:45h | UTCNews Release: Combination anti-HIV antibody infusions suppress virus for prolonged period – National Institutes of Health
Original Study: Combination anti-HIV antibodies provide sustained virological suppression – Nature
Commentaries on Twitter
Still don't get the enthusiasm for HIV Rx with bNAbs.
Compared to existing antivirals, they have:
– more baseline resistance
– the need to scale up new resistance tests
– more resource requirements (IV administration)
– … and, if like other monoclonals, $$$
What am I missing? https://t.co/7WZmIjutwE— Paul Sax (@PaulSaxMD) June 1, 2022
This is a wonderful advance.
"Our data demonstrate that combination therapy with broadly neutralizing monoclonal antibodies can provide long-term virological suppression without antiretroviral therapy in individuals with HIV"https://t.co/DKNVSlg3mC
— Michael Worobey (@MichaelWorobey) June 2, 2022